![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PubMed:33012858 / 0-192
Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims.
|
projects
Unselected / annnotation | Selected / annnotation | |
|
|
|